Ovaterra Launches New Prenatal Vitamins

Contains The Full Recommended Daily Allowance of Choline Unlike Most Prenatals
Designed in Collaboration with Best-Selling Fertility Author Rebecca Fett

NEW YORK, NY / ACCESSWIRE / April 18, 2022 / Ovaterra by Fertility Nutraceuticals, a woman-led, leading lifestyle reproductive health company, announced the launch of two new prenatal vitamin supplements, Advanced Prenatal and Advanced Prep 35-39. They are unique prenatal capsules formulated with the full recommended daily value of Choline for pregnant and nursing women packaged in individual servings for women on the go. Advanced Prep 35-39 includes 25mg of patented FERTINATAL Micronized DHEA and is the singular prenatal on the market designed specifically for women aged 35-39.

The company’s new prenatal supplements were developed in collaboration with Rebecca Fett, Amazons #1 best-selling fertility author, whose books include It Starts with the Egg and Brain Health from Birth. Her background in molecular biology and biochemistry, as well as patent law, combined with her evidenced based research and her own fertility experience, was key in developing these unique prenatal vitamins. Going beyond what is traditionally offered in current supplements on the market, Fett and Ovaterra worked together to specifically formulate products designed to support women at an advanced reproductive age.

“With her focus on evidence-based research and clinical studies, Rebecca has been an influential thought leader in our field for the last 5 years,” stated Jodi Neuhauser, Co-Founder and CEO of Ovaterra. “Rebecca had been thinking about formulating her own line of supplements for a number of years, and we are honored that she chose to partner with us. Her evidence-based approach to supporting reproductive health is a perfect complement to what we do at Ovaterra.” Jodi continued, “As a brand, we say quality is non-negotiable and knowledge is power – and we mean it. Guided by our team of scientists and medical professionals, and over 18 years of research, we are dedicated to developing the highest quality products and technology to help support women’s reproductive health,” Jodi continued.

Ovaterra offers nutritional supplements for forward-thinking and holistic providers and their patients, including integrative practitioners, reproductive endocrinologists, urologists, OBGYNs, nutritionists and health coaches. Products are designed specifically to support the structure and function of sexual and reproductive organs and women’s health, from preconception to menopause. The company utilizes FDA good manufacturing practices in producing quality products in bioavailable forms. All of Ovaterra’s products are gluten-free, vegetarian, non-GMO and nut free, and are formulated to not have artificial colors, flavors, sweeteners or preservatives as ingredients.

Features of Ovaterra’s new Advanced Prenatal supplements include:

• 24 optimal vitamins and minerals in their bioavailable form for comprehensive nourishment.
• Made up of 6 capsules to fit in a number of beneficial nutrients versus many prenatals which are only 1-2 capsules.
• Available in individual daily packs for women-on-the-go, a 4 week supply.
• Designed specifically to support all women trying to conceive, including women of advanced reproductive age, and to provide support beyond what some other traditional prenatals provide.
• Supplements are designed to be taken 3 months before pregnancy, during pregnancy and 3 months after pregnancy to support women’s reproductive function, including fertility, pregnancy and postpartum health.

Ovaterra’s scientific team is led by Dr. Norbert Gleicher MD, FACOG, FACS; Dr. David Barad MD, MS, FACOG; and Dr. Bruce Hollis Ph.D. Each product the company develops is done so alongside a leading researcher in the field. The company’s most recent product introduction, Vitamin D3+ K2, was designed in collaboration with Dr. Hollis, the leading expert in Vitamin D’s role in pregnancy and pediatric development. The company sources quality ingredients from FDA GMP-compliant suppliers, and every product is evaluated for their specific impact on female reproductive health. Products are triple tested and independently verified to ensure the potency and quality as part of product development. Ovaterra holds 10 patents for formulations and technology in the United States and Canada.

Both products are available now through select retailers, doctors, and fertility clinics. Retailers include myovaterra.com and Amazon.com, as well as specialty pharmacies. Select fertility clinics include The Center for Human Reproduction, Advanced Reproductive Center of Hawaii and Harley Street Fertility Clinic. The products are also available in the United Kingdom at Zen Pharmacy and the Harley Street Fertility Clinic.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

About Ovaterra

Born out of research, Ovaterra is a lifestyle reproductive health company providing doctors, patients and their partners with the research, quality products and personalized services to make the most of their reproductive lives. The company is evolving to focus on creating a fully-integrated personalized reproductive health platform and ecosystem of related products and services based on the latest in scientific research – delivered with a human touch. Ovaterra is woman-led and based in New York City. For more information, visit www.myovaterra.com or follow us @ovaterra.

Contacts:

For product information:
Jodi Neuhauser, Co-Founder & CEO, Ovaterra
212-628-0851
info@myovaterra.com

For Media Inquiries
Maria Rosati, Eminence Communications
917-478-2290
Mrosati@eminencenyc.com

SOURCE: Ovaterra by Fertility Nutraceuticals

View source version on accesswire.com:
https://www.accesswire.com/697804/Ovaterra-Launches-New-Prenatal-Vitamins